Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists: A Prospective, Observational, Phase IV Study (DELAY)

NCT01366053 is registered in ClinicalTrials.gov with CMX Research as lead sponsor.

NCT NCT01366053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01366053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists: A Prospective, Observational, Phase IV Study (DELAY)
Lead sponsor
CMX Research
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
July 31, 2015
Enrollment
125 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer